• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. JRNY II CR FEM COCR NP RT SZ 4; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. JRNY II CR FEM COCR NP RT SZ 4; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL Back to Search Results
Catalog Number 74021254
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Loss of Range of Motion (2032); Fibrosis (3167)
Date of Event 04/10/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported after primary cori assisted tka surgery on (b)(6) 2024 where a jrny ii cr system was implanted.Six weeks post-op on 10-abr-2024 the patient presented arthrofibrosis on the right knee, which also caused loss of range of motion.The patient is scheduled for an manipulation under anesthesia on (b)(6) 2024 and their outcome is recovering.Further complications have not been reported.
 
Additional Manufacturer Narrative
Internal complaint reference: case (b)(4).
 
Additional Manufacturer Narrative
B2: outcomes attributed to adverse event.Section h3, h6: although the involvement of all the devices was reported, the relationship with the investigated failure was directly associated to the femoral component, the tibial baseplate, the insert and the patella.Given the nature of the alleged incident, the device could not be returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that the provided electronic clinical report forms show the onset date as (b)(6) 2024 for the severe arthrofibrosis, noting the serious event as anticipated, unrelated to the cori tensioner, possibly related to the procedure.A manipulation under anesthesia was performed (b)(6) 2024 and the patient is recovering/resolving.Arthrofibrosis is a known potential post-total knee arthroplasty occurrence and is not indicative of a component malperformance.No contributing clinical factors were identified from the provided electronic clinical report forms.A review of the production orders did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.For the femoral component, the insert and the patella, a review of complaint history for the part number over the past 12 months and for the batch number based on historical data of the device did not reveal similar events for the listed device.For the tibial baseplate, a review of complaint history revealed similar events for the listed device over the previous 12 months, but no similar events for the batch based on the historical data, this failure mode will be monitored for future complaints for any necessary corrective actions.A review of the instructions for use documents for knee systems revealed in possible adverse effects that decreased range of motion and unusual stress concentrations can result from trauma, improper implant selection, improper implant positioning, improper fixation, and/or migration of the components.Muscle and fibrous tissue laxity can also contribute to these conditions.A review of the risk management files revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to these products and event.At this time, we have no evidence to conclude that the product failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include but not limited to trauma, post operative care, patient medical history and/or patient condition.Based on this investigation, the need for corrective action is not indicated.Should additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.H6: health effect - impact code f2308 medical treatment under anaesthesia.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JRNY II CR FEM COCR NP RT SZ 4
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key19259336
Report Number1020279-2024-00886
Device Sequence Number17772024
Product Code JWH
UDI-Device Identifier00885556615164
UDI-Public00885556615164
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
K121443
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number74021254
Device Lot NumberB2017863
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/12/2024
Supplement Date Received by Manufacturer05/28/2024
Initial Report FDA Received Date05/07/2024
Supplement Report FDA Received Date06/03/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/12/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
74022213/23KM00985/JOURNEY TIBIA BASE NP RT SZ 3.; 74024829/15CM18940/JRNY BCS PAT RESRF RD 29 MM STD.; 74025632/20LM03028/JRNY II CR ISRT XLPE RT SZ 3-4.
Outcome Attributed to Adverse Event Other;
Patient Age45 YR
Patient SexFemale
Patient Weight73 KG
-
-